Home
Conditions
Parasitic Diseases

Clinical trial condition

Parasitic Diseases

Explore clinical trials studying Parasitic Diseases. Study availability and eligibility vary by location and protocol.

1,788 public trials 101 recruiting studies

Refine in advanced search Browse all conditions

Parasitic Diseases trial results

Completed

VAC 072-An Efficacy Study of R21/MM in Different Dose Schedules

NCT03970993

Conditions: Infections, Malaria, Mosquito-Borne Diseases, +3 more
Locations: Guy's and St Thomas' NHS Foundation Trust London, United Kingdom

Imperial College Healthcare NHS Trust London, United Kingdom

CCVTM, University of Oxford, Churchill Hospital Oxford, United Kingdom

University Hospital Southampton NHS Foundation Trust Southampton, United Kingdom

View Trial Details

Completed

Safety of KAE609 in Adults With Uncomplicated Plasmodium Falciparum Malaria.

NCT03334747

Conditions: Infections, Malaria, Mosquito-Borne Diseases, +3 more
Locations: Novartis Investigative Site Lambaréné, Gabon

Novartis Investigative Site Kintampo, Ghana

Novartis Investigative Site Navrango, Ghana

Novartis Investigative Site Bamako, Mali

View Trial Details

Completed

Safety, Tolerability and Protective Efficacy of PfSPZ Vaccine in Gabonese Children

NCT03521973

Conditions: Infections, Malaria, Malaria, Falciparum, +4 more
Locations: Centre de Recherches Médicales de Lambaréné (CERMEL) Lambaréné, Moyen-Ogooué Province, Gabon

View Trial Details

Completed

Efficacy of Antimalarial Drugs Used for the Treatment of Uncomplicated Malaria, Plasmodium Falciparum, at the Agadez, Gaya and Tessaoua Sentinel Sites

NCT05070520

Conditions: Infections, Malaria, Mosquito-Borne Diseases, +3 more
Locations: Programme National de Lutte Contre Le Paludisme Niamey, Niger

View Trial Details

Completed

Therapeutic Efficacy Study of AL and DP in Western Kenya

NCT05060198

Conditions: Infections, Malaria, Malaria, Falciparum, +5 more
Locations: Not specified

View Trial Details

Completed

Immunogenicity and Safety Study of GSK Biologicals' Candidate Malaria Vaccine Given at 6, 7.5 and 9 Months of Age in Co-administration With Measles, Rubella and Yellow Fever (YF) Vaccines Followed by a Booster of the Malaria Vaccine.

NCT02699099

Conditions: Infections, Malaria, Malaria Vaccines, +5 more
Locations: GSK Investigational Site Kintampo, Ghana

GSK Investigational Site Kumasi, Ghana

View Trial Details

Completed

Comparison of Arterolane-piperaquine Versus Arterolane-piperaquine+Mefloquine Versus Artemether-lumefantrine in Kenyan Children

NCT03452475

Conditions: Infections, Malaria, Malaria, Falciparum, +5 more
Locations: Kilifi County Hospital Kilifi, Kenya

View Trial Details

Completed

MAMAS: Mentoring Adolescent Mothers at School

NCT03090802

Conditions: Acquired Immunodeficiency Syndrome, Bacterial Infections, Bacterial Infections and Mycoses, +33 more
Locations: Philasende Clinic Umlazi, South Africa

View Trial Details

Completed

Clinical Trial Evaluating the Safety and Efficacy of Levamisole in Loa Loa Microfilaremic Patients

NCT04049630

Conditions: Eye Diseases, Eye Infections, Eye Infections, Parasitic, +11 more
Locations: Secteur opérationnelle de la Santé, Ministère de la Santé et de la Population Sibiti, Republic of the Congo

View Trial Details

Completed

Evaluation of Reactive Focal Mass Drug Administration for Malaria Elimination in Swaziland

NCT02315690

Conditions: Infections, Malaria, Mosquito-Borne Diseases, +3 more
Locations: Swaziland Ministry of Health Mbabane, Eswatini

View Trial Details

Parasitic Diseases

Parasitic Diseases trial results

Related conditions